{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF00047",
      "entity_text" : "Ig",
      "entity_type" : "family"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0087" ],
      "Species" : [ "taxonomy:12721" ]
    }
  },
  "verbose_text" : "A longer period of observation should be addressed in patients presenting with low Ig levels prior to rituximab-therapy or in those who show risk factors for prolonged / severe hypogammaglobulinemia.",
  "reading_complete" : "2020-08-04T12:54:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:53:27Z",
  "trigger" : "levels",
  "evidence" : [ "Ig levels" ],
  "pmc_id" : "4259107",
  "score" : 0
}